IP Verse

Agent For Use In Treatment Or Prevention Of Ophthalmic Disorders

Patent No. EP4031117 (titled "Agent For Use In Treatment Or Prevention Of Ophthalmic Disorders") was filed by Chiesi Farmaceutici on Sep 15, 2020. The application was issued on Jul 24, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANApr 23, 2025HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4031117

CHIESI FARMACEUTICI
Application Number
EP20775227A
Filing Date
Sep 15, 2020
Status
Granted And Under Opposition
Jun 20, 2024
Publication Date
Jul 24, 2024
External Links
Slate, Register , Google Patents